28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A lactate-induced response to hypoxia.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Organisms must be able to respond to low oxygen in a number of homeostatic and pathological contexts. Regulation of hypoxic responses via the hypoxia-inducible factor (HIF) is well established, but evidence indicates that other, HIF-independent mechanisms are also involved. Here, we report a hypoxic response that depends on the accumulation of lactate, a metabolite whose production increases in hypoxic conditions. We find that the NDRG3 protein is degraded in a PHD2/VHL-dependent manner in normoxia but is protected from destruction by binding to lactate that accumulates under hypoxia. The stabilized NDRG3 protein binds c-Raf to mediate hypoxia-induced activation of Raf-ERK pathway, promoting angiogenesis and cell growth. Inhibiting cellular lactate production abolishes the NDRG3-mediated hypoxia responses. Our study, therefore, elucidates the molecular basis for lactate-induced hypoxia signaling, which can be exploited for the development of therapies targeting hypoxia-induced diseases.

          Related collections

          Author and article information

          Journal
          Cell
          Cell
          1097-4172
          0092-8674
          Apr 23 2015
          : 161
          : 3
          Affiliations
          [1 ] Medical Genomics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 305-806, Korea.
          [2 ] Department of Life Science, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea.
          [3 ] Korean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 305-806, Korea.
          [4 ] Department of Pathology, Inje University Seoul Paik Hospital, Seoul 100-032, Korea.
          [5 ] Medical Genomics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 305-806, Korea; Department of Functional Genomics, Korea University of Science and Technology, Daejeon 305-350, Korea.
          [6 ] Research Center for Integrative Cellulomics, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 305-806, Korea; Department of Functional Genomics, Korea University of Science and Technology, Daejeon 305-350, Korea.
          [7 ] Medical Genomics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 305-806, Korea. Electronic address: kpark@kribb.re.kr.
          [8 ] Medical Genomics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 305-806, Korea; Ochang Branch Institute, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 305-806, Korea; Department of Functional Genomics, Korea University of Science and Technology, Daejeon 305-350, Korea. Electronic address: yeomyi@kribb.re.kr.
          Article
          S0092-8674(15)00264-0
          10.1016/j.cell.2015.03.011
          25892225
          439a283d-f429-4829-887d-1cb1ec7dd59d
          Copyright © 2015 Elsevier Inc. All rights reserved.
          History

          Comments

          Comment on this article